A Study of the Clinicopathological Effects of Chemotherapy for Human Esophageal Carcinoma
The prognosis of esophageal carcinoma is not good in spite of technical advances in both surgery and radiation therapy [1, 2]. Our total resections of epidermoid carcinoma of the esophagus consist of 201 cases in the past 10 years, though the survival rate, among 102 cases after 5 years, is only 12%. Ninety percent of the patients who were admitted to us were in the advanced stages of the disease, so this is one of the reasons why esophageal carcinoma has such a poor prognosis, compared with other carcinomas of the digestive organs.
KeywordsEsophageal Cancer Esophageal Carcinoma Epidermoid Carcinoma Esophageal Disease Distant Lymph Node Metastasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Pearson JG (1971) The value of radiotherapy of the management of squamous esophageal cancer. Br J Surg 58:794–804PubMedCrossRefGoogle Scholar
Nakayama K, Kinoshita Y (1974) Surgical treatment combined with preoperative concentrated irradiation. JAMA 222:178–181CrossRefGoogle Scholar
Davis S, Shanmwgathasa M, Kessler W (1980) Cis-Dichlorodiamineplatinum(II) in the treatment of esophageal carcinoma. Cancer Treat Rep 64:709–711PubMedGoogle Scholar
Kelsen DP, Ahuja R, Hopfan S, Bains MS, Kosloff C, Martini N, McCormack P, Golbey B (1981) Combined modality therapy of esophageal carcinoma. Cancer 48:31–37PubMedCrossRefGoogle Scholar
Kelsen DP, Bains M, Chapman R, Golbey R (1981) Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma. Cancer Treat Rep 65:781–785PubMedGoogle Scholar